Home / Health / Cancelled N.B. Pharmacy Pilot Showed High Demand
Cancelled N.B. Pharmacy Pilot Showed High Demand
21 Jan
Summary
- About 30% of patients lacked other healthcare options.
- Two-thirds of clients had a primary care provider.
- Pilot offered chronic disease management and strep testing.
A report examining a past pilot program in New Brunswick has highlighted the demand for expanded pharmacy services. Data collected during the pilot indicated that approximately 30% of patients involved had no alternative healthcare options, underscoring the need for such initiatives. The program, launched in 2023, allowed pharmacists to manage chronic conditions and offer point-of-care testing for strep throat.
While two-thirds of clients reported having a primary care provider, this figure dropped significantly for those seeking care for chronic diseases. Pharmacist prescriptions were the most common intervention for these patients. Despite positive patient feedback and demonstrated feasibility, the pilot was terminated in 2025.
Health officials stated the decision was made to integrate pharmacists into collaborative care teams rather than fund a standalone pharmacy model. However, proponents argue the pilot showed significant benefits and potential for improving patient access to care, suggesting it should remain a consideration for future healthcare system planning.
